Reply
- 1 January 2021
- journal article
- letter
- Published by Elsevier BV in Gastroenterology
- Vol. 160 (1), 476-477
- https://doi.org/10.1053/j.gastro.2020.10.045
Abstract
No abstract availableFunding Information
- Janssen Pharmaceuticals
- Novartis
- Arrien Pharmaceuticals
- Boehringer Ingelheim
- Shire
- Pfizer
- Merck
- Takeda Pharmaceutical Company
This publication has 6 references indexed in Scilit:
- Association Between Early-life Exposures and Inflammatory Bowel Diseases, Based on Analyses of Deciduous TeethGastroenterology, 2020
- Deep Remission at 1 Year Prevents Progression of Early Crohn’s DiseaseGastroenterology, 2020
- Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before DiagnosisGastroenterology, 2020
- 400 GM-CSF AUTOANTIBODIES PRECEDE THE DEVELOPMENT OF CROHN'S DISEASE AND PREDICT COMPLICATED PHENOTYPE AT DIAGNOSISGastroenterology, 2020
- An untargeted metabolomics method for archived newborn dried blood spots in epidemiologic studiesMetabolomics, 2017
- Deployment-Associated Exposure Surveillance With High-Resolution MetabolomicsJournal of Occupational and Environmental Medicine, 2016